لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Wienke J; Center for Translational Immunology., Brouwers L; Wilhelmina Children's Hospital Birth Center., van der Burg LM; Center for Translational Immunology., Mokry M; Regenerative Medicine Utrecht.; Laboratory of Clinical Chemistry and Hematology, and., Scholman RC; Center for Translational Immunology., Nikkels PG; Department of Pathology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Netherlands., van Rijn BB; Wilhelmina Children's Hospital Birth Center.; Obstetrics and Fetal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., van Wijk F; Center for Translational Immunology.

المصدر: JCI insight [JCI Insight] 2020 Sep 17; Vol. 5 (18). Date of Electronic Publication: 2020 Sep 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE

مواضيع طبية MeSH: Adaptation, Physiological*, Fetus/*metabolism , Lymphocytes, Tumor-Infiltrating/*immunology , Neoplasms/*pathology , Placenta/*metabolism , T-Lymphocytes, Regulatory/*immunology , Uterus/*metabolism, Cesarean Section ; Female ; Fetus/immunology ; Humans ; Lymphocytes, Tumor-Infiltrating/metabolism ; Maternal-Fetal Exchange ; Neoplasms/genetics ; Neoplasms/immunology ; Neoplasms/metabolism ; Placenta/immunology ; Pregnancy ; T-Lymphocytes, Regulatory/metabolism ; Transcriptome ; Uterus/immunology

المؤلفون: Crommelin HA; Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands., van der Burg LM; Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands; Science Department, University College Roosevelt, Middelburg, The Netherlands., Vorselaars AD; Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands., Drent M; Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands; Department of Pharmacology and Toxicology, Faculty of Health, Medicine and Life Sciences, Maastricht University, The Netherlands., van Moorsel CH; Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands; Division of Heart and Lungs, University Medical Center Utrecht, The Netherlands., Rijkers GT; Science Department, University College Roosevelt, Middelburg, The Netherlands; Department of Medical Microbiology and Immunology, St Antonius Hospital, Nieuwegein, The Netherlands., Deneer VH; Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands. Electronic address: v.deneer@antoniusziekenhuis.nl., Grutters JC; Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands; Division of Heart and Lungs, University Medical Center Utrecht, The Netherlands.

المصدر: Respiratory medicine [Respir Med] 2016 Jun; Vol. 115, pp. 72-7. Date of Electronic Publication: 2016 Apr 23.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Adalimumab/*pharmacology , Antirheumatic Agents/*pharmacology , Infliximab/*adverse effects , Sarcoidosis/*drug therapy , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Adult ; Aged ; Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized/adverse effects ; Antibodies, Monoclonal, Humanized/therapeutic use ; Drug Hypersensitivity ; Female ; Humans ; Male ; Middle Aged ; Netherlands/epidemiology ; Receptors, Interleukin-2 ; Retrospective Studies ; Sarcoidosis/diagnosis ; Sarcoidosis/metabolism ; Treatment Outcome ; Tumor Necrosis Factor-alpha/adverse effects ; Tumor Necrosis Factor-alpha/metabolism ; Vital Capacity/drug effects